X4制药(XFOR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XFOR X4制药

休市中 07-26 16:00:00 EDT

0.8620

-0.0028

-0.32%

盘后0.8600

-0.0020-0.23%

19:29 EDT

最高0.8900	最低0.8328	成交量106.78万
今开0.8900	昨收0.8648	日振幅6.61%
总市值1.45亿	流通市值1.10亿	总股本1.68亿
成交额92.33万	换手率0.84%	流通股本1.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"XFOR","market":"US","secType":"STK","nameCN":"X4制药","latestPrice":0.862,"timestamp":1722024000000,"preClose":0.8648,"halted":0,"volume":1067831,"hourTrading":{"tag":"盘后","latestPrice":0.86,"preClose":0.862,"latestTime":"19:29 EDT","volume":14056,"amount":12161.362,"timestamp":1722036553775},"delay":0,"floatShares":127879750,"shares":167937781,"eps":-0.673813,"marketStatus":"休市中","marketStatusCode":7,"change":-0.0028,"latestTime":"07-26 16:00:00 EDT","open":0.89,"high":0.89,"low":0.8328,"amount":923270.9223637,"amplitude":0.066142,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.673813,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1722240000000},"adr":0,"listingDate":1510808400000,"adjPreClose":0.8648,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.897,"preClose":0.8648,"latestTime":"09:08 EDT","volume":673,"amount":604.2708172,"timestamp":1721999328397},"postHourTrading":{"tag":"盘后","latestPrice":0.86,"preClose":0.862,"latestTime":"19:29 EDT","volume":14056,"amount":12161.362,"timestamp":1722036553775},"volumeRatio":0.7391525008754662,"impliedVol":1.6397,"impliedVolPercentile":0.5556},"requestUrl":"/m/hq/s/XFOR/wiki","defaultTab":"wiki","newsList":[{"id":"2454808611","title":"X4制药盘中异动 股价大涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454808611","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454808611?lang=zh_cn&edition=full","pubTime":"2024-07-25 22:59","pubTimestamp":1721919558,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日22时59分，X4制药股票出现异动，股价快速上涨5.57%。截至发稿，该股报0.878美元/股，成交量23.1552万股，换手率0.14%，振幅5.78%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体跌幅为0.57%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725225918af9420eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725225918af9420eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2454836629","title":"X4制药盘中异动 急速上涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454836629","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454836629?lang=zh_cn&edition=full","pubTime":"2024-07-25 01:48","pubTimestamp":1721843324,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日01时48分，X4制药股票出现异动，股价快速拉升5.25%。截至发稿，该股报0.869美元/股，成交量65.9859万股，换手率0.39%，振幅6.75%。X4制药股票所在的生物技术行业中，整体涨幅为0.45%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家后期临床生物制药公司，致力于研究和开发治疗罕见疾病和治疗选择有限的疾病的新型疗法，重点关注由免疫系统功能障碍引起的疾病。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407250148449681fe3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407250148449681fe3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2453753056","title":"X4制药盘中异动 早盘大幅上涨5.24%报0.839美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453753056","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453753056?lang=zh_cn&edition=full","pubTime":"2024-07-23 23:01","pubTimestamp":1721746867,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日23时01分，X4制药股票出现异动，股价急速拉升5.24%。截至发稿，该股报0.839美元/股，成交量51.0272万股，换手率0.30%，振幅8.12%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.28%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723230108aefb04fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723230108aefb04fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2453171047","title":"X4制药盘中异动 股价大涨5.40%报0.800美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453171047","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453171047?lang=zh_cn&edition=full","pubTime":"2024-07-23 03:58","pubTimestamp":1721678339,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日03时58分，X4制药股票出现异动，股价急速拉升5.40%。截至发稿，该股报0.800美元/股，成交量105.861万股，换手率0.63%，振幅7.77%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-51.77百万美元，每股收益-0.26美元，毛利-62000.00美元，市盈率-1.16倍。X4制药股票所在的生物技术行业中，整体涨幅为0.99%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723035900aefacf1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723035900aefacf1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2451691334","title":"X4制药盘中异动 急速上涨5.16%报0.746美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451691334","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451691334?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:47","pubTimestamp":1721137626,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时47分，X4制药股票出现异动，股价快速拉升5.16%。截至发稿，该股报0.746美元/股，成交量3.7738万股，换手率0.02%，振幅3.20%。X4制药股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Silo Pharma, Inc.、Scisparc Ltd.、Conduit Pharmaceuticals Inc.涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1614.18%、762.69%、88.46%，振幅较大的相关个股有Scisparc Ltd.、Aeon Biopharma, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为40.48%、36.40%、34.67%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716214706941f770f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716214706941f770f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2450853537","title":"X4制药盘中异动 股价大涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450853537","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450853537?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:39","pubTimestamp":1720791569,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时39分，X4制药股票出现波动，股价急速拉升5.51%。截至发稿，该股报0.730美元/股，成交量13.3322万股，换手率0.08%，振幅4.86%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.72%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213929af921d03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213929af921d03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2450362366","title":"X4制药盘中异动 早盘大幅上涨5.05%报0.645美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450362366","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450362366?lang=zh_cn&edition=full","pubTime":"2024-07-11 23:19","pubTimestamp":1720711170,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日23时19分，X4制药股票出现波动，股价急速上涨5.05%。截至发稿，该股报0.645美元/股，成交量71.2668万股，换手率0.42%，振幅5.39%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-51.77百万美元，每股收益-0.26美元，毛利-62000.00美元，市盈率-0.96倍。X4制药股票所在的生物技术行业中，整体涨幅为0.55%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711231930941f651d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711231930941f651d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2450381342","title":"X4制药盘中异动 早盘快速拉升6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450381342","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450381342?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:59","pubTimestamp":1720619985,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时59分，X4制药股票出现波动，股价大幅上涨6.04%。截至发稿，该股报0.630美元/股，成交量10.0951万股，换手率0.06%，振幅3.25%。X4制药股票所在的生物技术行业中，整体涨幅为0.01%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家后期临床生物制药公司，致力于研究和开发治疗罕见疾病和治疗选择有限的疾病的新型疗法，重点关注由免疫系统功能障碍引起的疾病。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710215945941f5d71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710215945941f5d71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2450932075","title":"X4制药盘中异动 下午盘急速拉升5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450932075","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450932075?lang=zh_cn&edition=full","pubTime":"2024-07-10 01:36","pubTimestamp":1720546587,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日01时36分，X4制药股票出现异动，股价急速上涨5.28%。截至发稿，该股报0.612美元/股，成交量86.3399万股，换手率0.51%，振幅8.15%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体跌幅为0.26%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710013627941f57b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710013627941f57b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2449703286","title":"X4制药盘中异动 早盘股价大涨6.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449703286","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449703286?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:35","pubTimestamp":1720445704,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时35分，X4制药股票出现异动，股价急速上涨6.41%。截至发稿，该股报0.584美元/股，成交量11.6376万股，换手率0.07%，振幅2.55%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.14%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708213504aef87832&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708213504aef87832&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2448485906","title":"X4制药盘中异动 股价大涨5.05%报0.572美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448485906","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448485906?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:41","pubTimestamp":1720014108,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日21时41分，X4制药股票出现异动，股价快速上涨5.05%。截至发稿，该股报0.572美元/股，成交量16.0949万股，换手率0.10%，振幅1.80%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-51.77百万美元，每股收益-0.26美元，毛利-62000.00美元，市盈率-0.85倍。X4制药股票所在的生物技术行业中，整体跌幅为0.21%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703214148af9065c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703214148af9065c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2448415036","title":"X4制药盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448415036","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448415036?lang=zh_cn&edition=full","pubTime":"2024-07-02 22:16","pubTimestamp":1719929788,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日22时16分，X4制药股票出现异动，股价大幅下跌5.04%。截至发稿，该股报0.560美元/股，成交量46.793万股，换手率0.28%，振幅4.63%。X4制药股票所在的生物技术行业中，整体跌幅为1.16%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家后期临床生物制药公司，致力于研究和开发治疗罕见疾病和治疗选择有限的疾病的新型疗法，重点关注由免疫系统功能障碍引起的疾病。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070222162896818d6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070222162896818d6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2448716918","title":"X4制药盘中异动 股价大涨5.28%报0.611美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448716918","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448716918?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:31","pubTimestamp":1719840661,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时31分，X4制药股票出现波动，股价快速拉升5.28%。截至发稿，该股报0.611美元/股，成交量10.8542万股，换手率0.06%，振幅0.26%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体跌幅为0.05%。消息层面，截至21时31分，《H.C. Wainwright维持X4制药买入评级，维持目标价5美元》资讯为影响X4制药的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407012131019eed388a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407012131019eed388a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2446238553","title":"X4制药盘中异动 早盘快速跳水15.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446238553","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446238553?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:32","pubTimestamp":1719495121,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时32分，X4制药股票出现波动，股价快速下跌15.99%。截至发稿，该股报0.840美元/股，成交量126.439万股，换手率0.75%，振幅5.60%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406272132019f6c16b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406272132019f6c16b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2446929433","title":"X4制药盘中异动 股价大涨5.20%报1.010美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446929433","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446929433?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:36","pubTimestamp":1719412619,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时36分，X4制药股票出现波动，股价快速拉升5.20%。截至发稿，该股报1.010美元/股，成交量19.4332万股，换手率0.12%，振幅4.25%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-51.77百万美元，每股收益-0.26美元，毛利-62000.00美元，市盈率-1.49倍。X4制药股票所在的生物技术行业中，整体跌幅为0.89%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626223659941f16c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626223659941f16c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0},{"id":"2446009873","title":"X4制药盘中异动 急速下挫5.03%报0.959美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446009873","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446009873?lang=zh_cn&edition=full","pubTime":"2024-06-26 03:24","pubTimestamp":1719343471,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日03时24分，X4制药股票出现波动，股价急速下跌5.03%。截至发稿，该股报0.959美元/股，成交量121.74万股，换手率0.72%，振幅6.93%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为1.82%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626032431af8f2489&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626032431af8f2489&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2445996897","title":"X4制药盘中异动 急速拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445996897","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445996897?lang=zh_cn&edition=full","pubTime":"2024-06-22 02:57","pubTimestamp":1718996279,"startTime":"0","endTime":"0","summary":"北京时间2024年06月22日02时57分，X4制药股票出现异动，股价急速上涨5.21%。截至发稿，该股报1.010美元/股，成交量83.4076万股，换手率0.50%，振幅5.56%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.18%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622025759af8eaaad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622025759af8eaaad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2444116797","title":"X4制药盘中异动 临近收盘快速跳水5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444116797","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444116797?lang=zh_cn&edition=full","pubTime":"2024-06-18 03:43","pubTimestamp":1718653422,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日03时43分，X4制药股票出现异动，股价大幅跳水5.11%。截至发稿，该股报0.968美元/股，成交量99.2824万股，换手率0.59%，振幅6.21%。X4制药股票所在的生物技术行业中，整体涨幅为0.14%。X4制药公司简介：X4 Pharmaceuticals Inc 是一家后期临床生物制药公司，致力于研究和开发治疗罕见疾病和治疗选择有限的疾病的新型疗法，重点关注由免疫系统功能障碍引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061803434296814b01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061803434296814b01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2443725605","title":"X4制药盘中异动 股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443725605","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443725605?lang=zh_cn&edition=full","pubTime":"2024-06-15 01:30","pubTimestamp":1718386226,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日01时30分，X4制药股票出现波动，股价大幅下跌5.19%。截至发稿，该股报1.01美元/股，成交量35.2725万股，换手率0.21%，振幅2.83%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.09%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615013026af8da65e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615013026af8da65e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XFOR","BK4139"],"gpt_icon":0},{"id":"2443687178","title":"X4制药盘中异动 股价大跌5.41%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443687178","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443687178?lang=zh_cn&edition=full","pubTime":"2024-06-13 22:52","pubTimestamp":1718290362,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日22时52分，X4制药股票出现异动，股价大幅跳水5.41%。截至发稿，该股报1.05美元/股，成交量55.7536万股，换手率0.33%，振幅7.21%。机构评级方面，在所有6家参与评级的机构中，83%的券商给予买入建议，17%的券商给予持有建议，无券商给予卖出建议。X4制药股票所在的生物技术行业中，整体涨幅为0.34%。它还拥有两个临床前候选药物X4P-003和X4P-002，它们是具有不同性质的CXCR4拮抗剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613225242941ee653&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613225242941ee653&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XFOR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.x4pharma.com","stockEarnings":[{"period":"1week","weight":0.1357},{"period":"1month","weight":-0.138},{"period":"3month","weight":-0.2601},{"period":"6month","weight":0.1125},{"period":"1year","weight":-0.4929},{"period":"ytd","weight":0.028}],"compareEarnings":[{"period":"1week","weight":-0.0083},{"period":"1month","weight":-0.002},{"period":"3month","weight":0.0712},{"period":"6month","weight":0.117},{"period":"1year","weight":0.2032},{"period":"ytd","weight":0.1454}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"X4 Pharmaceuticals, Inc.于2010年8月2日根据特拉华州法律注册成立。该公司是一家晚期临床阶段的生物制药公司，发现和开发用于治疗罕见疾病和治疗选择有限的疾病的新疗法，重点关注免疫系统功能障碍导致的疾病。公司主导临床候选药物为mavorixafor，一种趋化因子受体CXCR4的小分子选择性拮抗剂。由于mavorixafor能够增加成熟、功能性白细胞进入血液的动员，他们认为mavorixafor有可能在多种慢性中性粒细胞减少性疾病中提供治疗益处，包括WHIM综合征，这是一种罕见的原发性免疫缺陷。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.003431},{"month":2,"riseRate":0.714286,"avgChangeRate":0.081966},{"month":3,"riseRate":0.571429,"avgChangeRate":0.137927},{"month":4,"riseRate":0.285714,"avgChangeRate":0.026234},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.016456},{"month":6,"riseRate":0.142857,"avgChangeRate":-0.244326},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.01377},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.084948},{"month":9,"riseRate":0.333333,"avgChangeRate":0.020336},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.100121},{"month":11,"riseRate":0.333333,"avgChangeRate":0.267309},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.202177}],"exchange":"NASDAQ","name":"X4制药","nameEN":"X4 Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"X4制药(XFOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供X4制药(XFOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"X4制药,XFOR,X4制药股票,X4制药股票老虎,X4制药股票老虎国际,X4制药行情,X4制药股票行情,X4制药股价,X4制药股市,X4制药股票价格,X4制药股票交易,X4制药股票购买,X4制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"X4制药(XFOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供X4制药(XFOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}